The Clorox Company $CLX Stock Position Raised by Texas Yale Capital Corp.

Texas Yale Capital Corp. grew its position in The Clorox Company (NYSE:CLX – Free Report) by 71.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 50,800 shares of the company’s stock after purchasing an additional 21,125 shares during the quarter. Texas Yale Capital Corp.’s holdings in Clorox were worth $4,115,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in CLX. Pension & Wealth Management Advisors Inc. bought a new position in Clorox during the 3rd quarter worth $26,000. Ancora Advisors LLC acquired a new stake in shares of Clorox during the second quarter worth $28,000. Avalon Trust Co acquired a new stake in shares of Clorox during the second quarter worth $29,000. Markowski Investments acquired a new stake in shares of Clorox during the second quarter worth $30,000. Finally, Barrett & Company Inc. boosted its position in shares of Clorox by 86.0% in the third quarter. Barrett & Company Inc. now owns 372 shares of the company’s stock valued at $30,000 after acquiring an additional 172 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Clorox stock opened at $104.75 on Friday. The stock’s fifty day moving average price is $90.43 and its two-hundred day moving average price is $99.41. The Clorox Company has a one year low of $79.12 and a one year high of $128.90. The company has a debt-to-equity ratio of 32.91, a current ratio of 0.65 and a quick ratio of 0.39. The firm has a market cap of $12.69 billion, a PE ratio of 17.66, a price-to-earnings-growth ratio of 3.49 and a beta of 0.59.

Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Monday, November 2nd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.48. The firm had revenue of $1.91 billion during the quarter, compared to the consensus estimate of $1.88 billion. Clorox had a return on equity of 608.30% and a net margin of 9.41%. The company’s revenue was up 33.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.85 EPS. As a group, research analysts expect that The Clorox Company will post 5.74 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 12th. Investors of record on Wednesday, January 27th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date of this dividend is Wednesday, January 27th. Clorox’s payout ratio is 89.93%.

Insider Buying and Selling

In related news, Director Pierre Breber purchased 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 4th. The stock was acquired at an average price of $100.06 per share, with a total value of $400,240.00. Following the completion of the purchase, the director directly owned 22,000 shares in the company, valued at $2,201,320. This trade represents a 22.22% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.51% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on CLX shares. Evercore upgraded shares of Clorox from an “underperform” rating to a “hold” rating and set a $99.00 price target on the stock in a research note on Monday, November 2nd. Morgan Stanley raised their price target on shares of Clorox from $87.00 to $94.00 and gave the stock an “equal weight” rating in a research report on Wednesday, November 4th. Jefferies Financial Group cut shares of Clorox from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $125.00 to $98.00 in a research note on Tuesday, July 28th. Citigroup cut their price objective on shares of Clorox from $97.00 to $90.00 and set a “neutral” rating for the company in a report on Wednesday, October 14th. Finally, Barclays cut their price objective on shares of Clorox from $84.00 to $80.00 and set an “underweight” rating for the company in a report on Friday, October 16th. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Reduce” and a consensus price target of $93.79.

Check Out Our Latest Stock Analysis on Clorox

Clorox Profile

(Free Report)

The Clorox Company is a consumer products company founded in 1913 and headquartered in Oakland, California. It makes and markets products for household cleaning, food, water filtration, personal care and pet care. Its portfolio includes Clorox disinfecting and cleaning products, Glad trash bags and food-storage products, Kingsford charcoal, Brita water filters, Hidden Valley dressings and sauces, Burt’s Bees personal-care products, and Fresh Step cat litter. The company also sells products under brands such as Pine-Sol and Liquid-Plumr.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.